TOP NEWS

GPT Healthcare IPO: Subscription Update, Price Band, and Important Dates

Australian Premium

February 22, 2023

New Delhi, India

GPT Healthcare IPO Subscription Update

Investors are closely monitoring the ongoing IPO of GPT Healthcare Ltd, which entered the Indian primary market today. The subscription status, price band, and other key details are crucial factors influencing investor sentiment.

Subscription Status: Moderate Interest

As of 11:00 AM on the opening day, the GPT Healthcare IPO has garnered moderate interest, with an overall subscription rate of 0.12 times. Notably, the retail portion has shown slightly higher enthusiasm, with a subscription rate of 0.23 times, while the NII portion stands at 0.04 times.

Price Band and Lot Size

The mid-sized multi-specialty hospital has set the price band for its public issue at ₹177 to ₹186 per equity share. Investors will be able to apply for shares in lots, with each lot comprising 80 shares.

Important Dates to Remember

The GPT Healthcare IPO opened today, February 22, 2024, and will remain open for subscription until February 26, 2024. Share allocation is tentatively scheduled for February 27, 2024. The listing on the BSE and NSE is expected on February 29, 2024, adhering to the T+3 listing rule.

Also Read Our Latest Analysis: The Sony-Zee Merger: Will The Deal Revive?

Grey Market Premium (GMP) and Investor Insights

Observers note that GPT Healthcare shares are trading at par in the grey market, indicating neither a premium nor a discount. This suggests a neutral sentiment among investors, prompting cautious consideration before making investment decisions.

Conclusion

With moderate subscription interest, a defined price band, and important dates outlined, investors are advised to conduct thorough research and analysis before participating in the GPT Healthcare IPO. Understanding market dynamics, company fundamentals, and investor sentiment are key to making informed investment decisions in the IPO market.

Check Latest: Rupee Vs Dollar

Disclaimer:

CurrencyVeda provides this news article for informational purposes only. We do not offer investment advice or recommendations. Before making any investment decisions, please conduct thorough research, consult with financial experts, and carefully consider your financial situation, risk tolerance, and investment goals. Investing in the stock market carries risks, and it’s essential to make informed choices based on your individual circumstances. CurrencyVeda is not liable for any actions taken based on the information provided in this article.